Publications by authors named "Stephane Cattan"

Claim this Profile
C
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study.
François Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, Jean-Marie Péron, Marilyne Debette-Gratien, Stéphane Cattan

Liver Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.
Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, Mohamed Bouattour, Julien Edeline, Stéphane Cattan

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, Amaddeo Giuliana, Thomas Decaens, Stéphane Cattan

Eur J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib/II trial of capmatinib plus spartalizumab spartalizumab alone in patients with pretreated hepatocellular carcinoma.
Armando Santoro, Eric Assenat, Thomas Yau, Jean-Pierre Delord, Michela Maur, Stephane Cattan

JHEP Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.
Massih Ningarhari, Marlène Bertez, Anne Ploquin, Nicolas Bertrand, Christophe Desauw, Stéphane Cattan

Liver Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann-Lii Cheng, Stéphane Cattan

Liver Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Stephane Cattan

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.
Stephen L Chan, Martin Schuler, Yoon-Koo Kang, Chia-Jui Yen, Julien Edeline, Stéphane Cattan

J Exp Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Masatoshi Kudo, Richard S Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.
Robin Kate Kelley, Baek-Yeol Ryoo, Philippe Merle, Joong-Won Park, Luigi Bolondi, Stéphane Cattan

ESMO Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial.
Jérôme Durand-Labrunie, Anne-Sophie Baumann, Ahmet Ayav, Valérie Laurent, Emmanuel Boleslawski, Stéphane Cattan

Int J Radiat Oncol Biol Phys· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MSH2 c.1022T>C, p.Leu341Pro is a founder pathogenic variation and a major cause of Lynch syndrome in the North of France.
Catherine Vermaut, Julie Leclerc, Francis Vasseur, Agnes Wacrenier, Tonio Lovecchio, Stephane Cattan

Genes Chromosomes Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In which context is physician empathy associated with cancer patient quality of life?
Sophie Lelorain, Stéphane Cattan, Florian Lordick, Anja Mehnert, Christophe Mariette

Patient Educ Couns· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Andrew X Zhu, Richard S Finn, Julien Edeline, Stephane Cattan, Sadahisa Ogasawara

Lancet Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally Advanced or Metastatic Pancreatic Adenocarcinoma: Easily Available Factors of Predictive Prolonged Survival Under Gemcitabine.
Anne Ploquin, Stephanie Truant, Guillaume Piessen, Perrine Vuagnat, Capucine Baldini, Stephane Cattan

In Vivo· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.
Loic Guerbau, Romain Gerard, Nicolas Duveau, Delphine Staumont-Sallé, Julien Branche, Stéphane Cattan

Inflamm Bowel Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
Lucie Coppin, Kanza Benomar, François Corfiotti, Stéphane Cattan, Florence Renaud

Pancreatology· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hereditary predisposition to cancers of the digestive tract, breast, gynecological and gonadal: focus on the Peutz-Jeghers].
Anthony Turpin, Stéphane Cattan, Julie Leclerc, Agnès Wacrenier, Sylvie Manouvrier-Hanu

Bull Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
Andrew X Zhu, Masatoshi Kudo, Eric Assenat, Stéphane Cattan, Yoon-Koo Kang

JAMA· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.
Abbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, Thibaud Renaut-Vantroys, Isabelle Rosa, Stephane Cattan

Hepatology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose FOLFIRI, surgery, and radiofrequency ablation for patients with unresectable liver metastases from colorectal cancer.
Mohamed Hebbar, Stéphanie Truant, Christophe Desauw, Geraldine Sergent-Baudson, Stephane Cattan

Anticancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a patient with atypical MUTYH-associated polyposis through detection of the KRAS c.34G>T mutation in liver metastasis.
Marie-Pierre Buisine, Stéphane Cattan, Agnès Wacrenier, Julie Leclerc, Sophie Lejeune

J Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.
Aziz Zaanan, Nicolas Williet, Mohamed Hebbar, Tienhan Sandrine Dabakuyo, Laetitia Fartoux, Stéphane Cattan

J Hepatol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.
Antoine Hollebecque, Olivier Bouché, Olivier Romano, Elodie Scaglia, Stéphane Cattan

Chemotherapy· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).
Laetitia Dahan, Frank Bonnetain, Marc Ychou, Emmanuel Mitry, Mohamed Gasmi, Stéphane Cattan

Gut· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis